SCHEMBL21628385

SCHEMBL21628385

CCc1ccc(Oc2ccc(C(N)=O)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 15/20 0.70
PARP15 Q460N3 4/20 0.70
PARP4 Q9UKK3 2/20 0.70
PARP14 Q460N5 2/20 0.70
ALDH1A1 P00352 2/20 0.70
KMT2A Q03164 1/20 0.70
PARP16 Q8N5Y8 1/20 0.70
PARP11 Q9NR21 1/20 0.70
CHEK2 O96017 1/20 0.56
PARP3 Q9Y6F1 1/20 0.56
PARP2 Q9UGN5 3/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
PARP1 P09874 1/20 0.55
TNKS O95271 1/20 0.54
TNKS2 Q9H2K2 1/20 0.54
OPRM1 P35372 1/20 0.52
OPRD1 P41143 1/20 0.52
OPRK1 P41145 1/20 0.52
RXRA P19793 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178439 0.88 ALDH1A1 (0.64) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL21628632 0.86 PARP10 (0.66) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL13686078 0.85 ALDH1A1 (0.55) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL3137816 0.84 PARP10 (1.00) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL755049 0.83 PARP10 (0.73) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL680470 0.83 MAPT (0.73) ALDH1A1KMT2ARXRARXRBMAOB
SCHEMBL835345 0.83 ALDH1A1 (0.77) PARP10PARP15ALDH1A1CA1CA2
SCHEMBL21628604 0.83 PARP10 (0.61) PARP10PARP15PARP4PARP14ALDH1A1
SCHEMBL4520699 0.82 CYP17A1 (0.58) PARP10ALDH1A1CHEK2CA1CA2
SCHEMBL10243616 0.82 CYP17A1 (0.58) PARP10ALDH1A1CHEK2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK PARP10 1897/4885PARP15 2681/4885PARP4 3046/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR PARP10 3512/4885PARP15 4342/4885PARP4 3902/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885PARP15 2818/4885PARP4 3288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.